PetMed Express Inc (PETS) Q2 2020 Earnings Call Transcript

PetMed Express Inc (PETS) Q2 2020 Earnings Call Transcript

PetMed Express Inc (NASDAQ:PETS) Q2 2020 Earnings Call Oct 26, 2020, 8:30 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants. Prepared Remarks: Operator. Good morning. Welcome to the PetMed Express Incorporated, …
See Original Article

Aurobindo Pharma to sell Natrol to US-based PE player for $550 million

HYDERABAD: Nearly six years after it acquired US-based nutritional supplements maker Natrol, Aurobindo Pharma on Monday said it is now selling it to US-based private equity player New Mountain Capital and its affiliate Jarrow Formulas Inc in an all-cash …
See Original Article

Find out who tops list of 2020 Best Places to Work winners – Extra large category

Delta Defense LLC is the top-ranked company in the Milwaukee Business Journal’s Best Places to Work extra-large category. In all, the paper is honoring eight firms in this category of companies with more than 200 employees. This year’s program drew about …
See Original Article

Future of UK aerospace 'in doubt' without EU deal

The future of the UK’s £34bn aerospace sector is at risk if ministers do not reach a deal with the EU over the mutual recognition of parts, the aviation trade body ADS says. It said a deal would not form part of any post Brexit trade deal, despite the sector …
See Original Article

Crinetics' acromegaly drug hits primary PhII endpoint, but investors can't make up their minds

A little more than two years after first going public, Crinetics Pharmaceuticals is nearing the Phase III trial for its lead program. That candidate, paltusotine, just posted positive Phase II data as a maintenance therapy for acromegaly early Monday morning.
See Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.